This is a news story, published by The National Cancer Institute's Center For Cancer Research | Center for Cancer Research, that relates primarily to RRP news.
For more disease research news, you can click here:
more disease research newsFor more news from The National Cancer Institute's Center For Cancer Research | Center for Cancer Research, you can click here:
more news from The National Cancer Institute's Center For Cancer Research | Center for Cancer ResearchOtherweb, Inc is a public benefit corporation, dedicated to improving the quality of news people consume. We are non-partisan, junk-free, and ad-free. We use artificial intelligence (AI) to remove junk from your news feed, and allow you to select the best health news, business news, entertainment news, and much more. If you like disease research news, you might also like this article about
Recurrent Respiratory Papillomatosis. We are dedicated to bringing you the highest-quality news, junk-free and ad-free, about your favorite topics. Please come every day to read the latest Breakthrough Therapy Designation news, gorilla adenovirus news, disease research news, and other high-quality news about any topic that interests you. We are working hard to create the best news aggregator on the web, and to put you in control of your news feed - whether you choose to read the latest news through our website, our news app, or our daily newsletter - all free!
Respiratory PapillomatosisThe National Cancer Institute's Center For Cancer Research | Center for Cancer Research
•87% Informative
The FDA granted the first -in-class investigational PRGN-2012 (a gorilla adenovirus-based gene therapy from Precigen Inc. ) Breakthrough Therapy Designation and Orphan Drug Designation for the treatment of RRP .
RRP is a rare, devastating HPV -mediated chronic disease that causes wart-like (benign) growths in the airways.
VR Score
93
Informative language
97
Neutral language
40
Article tone
formal
Language
English
Language complexity
70
Offensive language
not offensive
Hate speech
not hateful
Attention-grabbing headline
not detected
Known propaganda techniques
not detected
Time-value
long-living
External references
2
Source diversity
2
Affiliate links
no affiliate links